Bliss GVS Pharma Limited has informed the Exchange about the communication to the shareholders regarding tax deduction on the interim dividend declared on February 10, 2026.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the exchange that it is communicating with shareholders about the tax deduction (TDS) applicable on the interim dividend declared on February 10, 2026. This is a routine regulatory communication informing shareholders about the tax withholding provisions on dividend income. The exact TDS rates would depend on the shareholder's residential status and PAN availability. Shareholders are advised to refer to the detailed communication sent by the company for specific tax rates and exemptions.
This is a procedural compliance update and does not impact the company's fundamentals or stock price. Shareholders should review the communication to understand the tax that will be deducted from their dividend payout.